Skip to main content

Table 2 Methodological characteristics of the included studies

From: Does health economics research align with the disease burden in the Middle East and North Africa region? A systematic review of economic evaluation studies on public health interventions

Author (references)

Year of cost estimation

Population

Perspective

Time horizon*

Discount (%)

Included costs

Model internal validity

Double counting

Sensitivity analysis

Adibi et al. [21]

2003

Premarriage individuals

Healthcare system and societal

25

3

Direct medical cost

Yes

NA

One-way and multivariate

Al Abri et al. [22]

2016 to 2017

A hypothetical cohort of 20-year-old migrants arriving in Oman

Healthcare system

Lifetime

NR

Direct medical cost

No

No

One-way, two-way and PSA

Al‐Qudah et al. [23]

2014

OPD patients with general chronic diseases at Jordan university hospital

Hospital

3 months

NA

Direct medical cost

NA

NA

One-way and multivariate

Assanelli et al. [24]

2005

Young professional and recreational athletes

NR

NR

3

Direct medical cost

No

NA

One-way

Balicer et al. [25]

2018

Whole population

Healthcare system and societal

NR

NR

Direct and indirect costs

NA

NA

Multivariate

Barfar et al. [26]

2019

Low socioeconomic women aged 35 and higher

Healthcare system

1

NA

Direct medical cost

No

NA

One-way

Carvalho et al. [27]

2014

Women aged 15–45

NR

Lifetime

NR

Direct and indirect costs

Yes

NA

One-way and PSA

Chodick et al. [28]

2015

Physician and nurses aged < 45 years

Employer (healthcare payer)

20

3

Direct medical cost

No

NA

One-way

Chodick et al. [29]

2016

Healthcare workers

Healthcare system

20

3

Direct costs

No

No

One-way

Chowers [30]

2014

All pregnant women

Payer

100

3.5

Direct medical cost

Yes

No

Univariate and multivariate

Devine [31]

2017

Adult patients with vivax malaria

Healthcare provider

1

NA

Direct costs

No

No

One-way and PSA

El-Dahiyat [32]

2016

The whole population

NR

NR

NR

Product price

NA

NA

NR

El-Ghitany [33]

2012

People at intermediate and high risk scores for HCV infection

NR

NR

NR

Cost of testing

No

NA

NR

Eltabbakh et al. [34]

2015

Cirrhotic patients older than 18 years

NR

NR

NR

Direct medical cost

No

No

NR

Gamaoun et al. [35]

2010

Young adolescent girls (12 years) and women 35–59 years

NR

NR

3

Direct medical cost

No

NA

NR

Ginsberg et al. [36]

2011

Pregnant women, couples before marriage, relatives of subjects with thalassemia, and even school children

Healthcare system and societal

30

5

Direct and indirect costs

NA

NA

One-way

Ginsberg et al. [37]

2014

Females aged 12–65 years

Healthcare system

Lifetime

3

Direct costs

No

No

One-way

Ginsberg et al. [38]

2018

Men who have sex with men

Societal

NR

3

Direct costs

No

No

One-way

Ginsberg et al. [39]

2016

Females aged 12–65 years old

Healthcare system

100

3

Direct costs

No

No

One-way

Ginsberg et al. [40]

2019

Adults aged 20 and above

NR

1

NA

Direct and indirect costs

Yes

Yes

One-way

Haghighat et al. [41]

2017

Women aged 40–70 years

Healthcare system

50

3 and 5

Direct costs

No

No

One-way and PSA

Hamdani et al. [42]

2013

Primary care attendees with high levels of psychological distress and functional impairment

Healthcare system

1

NA

Direct costs

Yes

NA

NR

Howard et al. [43]

2017

Afghan refugee resided in Pakistan

Societal

5

3

Direct and indirect costs

No

Yes

Univariate

Hussain et al. [44]

2018

TB patients who had been on treatment for a minimum of 2 months

Patients, health facility and TB program

2

3

Direct and indirect costs

No

No

One-way

Javadinasab et al. [45]

2016

First-degree relatives (aged 40 years and above) of patients with colorectal cancer

Healthcare system

Lifetime

5

Direct medical cost

Yes

No

One-way and deterministic

Javanbakht [46]

2014

Adults and the elderly population

Healthcare system

20

NR

Direct costs

Yes

NA

PSA

Kashi et al. [47]

2013

Pregnant women

NR

Lifetime

3

Direct costs

No

No

PSA

Khneisser et al. [48]

2010

All newborn babies

NR

NR

NR

Direct costs

NA

NA

NR

Khneisser et al. [49]

2014

All male newborns

NR

NR

NR

Direct medical cost

NA

NA

NR

Kim et al. [50]

2013

40-year-old and asymptomatic- HCV average-risk adults in Egypt

Societal

40

3

Direct and indirect costs

Yes

Yes

One-way, two-way and PSA

Kim et al. [51]

2013

Pre-adolescent girls (by age 9)

Societal

Lifetime

3

Direct and indirect costs

Yes

Yes

One-way

Koren et al. [52]

2017

Pregnant women, husbands of affected women, and patients with β Thalassemia major

NR

50

NR

Direct medical cost

No

NA

NR

Lahiri et al. [53]

2104

The entire economically active population

Societal

100

3

Direct costs

No

NA

One-way

Leshno et al. [54]

2014

Average risk population (50 years and over)

NR

Lifetime

3

Direct costs

No

NA

One-way and two-way

Lim et al. [55]

NR

General population and people who inject drugs

Healthcare provider

NR

3.5

Direct medical cost

Yes

NA

One-way

Lohse et al. [56]

NR

Pregnant women

NR

NR

3

Direct costs

Yes

No

NR

Madae’en et al. [57]

2012

Hypothetical cohort of Jordanian male smokers aged 30 years or older

Public payer (MoH)

70

3

Direct medical costs

No

NA

One-way and PSA

Marseille et al. [58]

2014

Pregnant women

NR

Lifetime

3

Direct costs

No

No

One-way and multivariate

Mason et al. [59]

2016

General population

NR

10

3

Direct costs

No

NA

One-way

Messoudi et al. [60]

2008

Girls at 14 years and Women aged 30–49

Healthcare system

Lifetime

3

Direct medical cost

Yes

NA

One-way and two-way

Mostafa et al. [61]

2018

Population exposed to unsafe injection practices

Healthcare system

30

3.5

Direct medical cost

Yes

No

One-way

Mostafa et al. [62]

2008

Population exposed to unsafe injection practices (aged 15–59 years)

Healthcare system

26

3.5

Direct medical cost

Yes

No

One-way

Nahvijou et al. [63]

2012

Women over 15 years of age

Healthcare system

Lifetime

3

Direct medical costs

Yes

No

One-way

Okem et al. [64]

2013

Pregnant women

Payer

NR

NR

Direct medical cost

No

NA

NR

Ornoy et al. [65]

NR

People with attention deficit hyperactivity disorder

Societal

Lifetime

NR

Direct and indirect costs

NA

NA

NR

Ranson et al. [66]

2016

Cohort of smokers

Public sector provider

30–50

3–10

Direct and indirect costs

No

No

NR

Rashidian et al. [67]

2017

Iranian hospitals

Provider

10

5–10

Direct and indirect costs

No

NA

One-way

Rezaei-Hemami et al. [68]

2017

NR

MoH

1

NA

Direct costs

No

NA

One-way

Saygili et al. [69]

2012

Cancer patients receiving palliative care

Societal and patient

1 Month

NA

Direct and indirect costs

No

NA

One-way

Shamshiri et al. [70]

2016

3 – 5 days old neonates

Caregiver

82

3

Direct costs

Yes

No

One-way

Sharma et al. [71]

2012

Women aged 25–65 years

Societal

Lifetime

3

Direct costs

No

NA

One-way

Shlomai et al. [72]

2011

The whole population

MoH

200 Days

NA

Direct and work absence costs

Yes

Yes

One-way and PSA

Shmueli et al. [73]

2015

Moderate-to-heavy smokers aged 45 years or older

Healthcare system

Lifetime

3

Direct medical cost

Yes

No

One-way and PSA

Sladkevicius et al. [74]

2016

Neonates

Societal

Lifetime

3

Direct and indirect costs

No

NA

One-way and PSA

Verguet et al. [75]

2019

Heterosexual adult population (15–49-year-old)

NR

5

NR

Direct medical cost

No

No

One-way

Vijayaraghavan et al. [76]

2008

12 million children aged six months to 12 years and 5 million children aged 9 to 59 months

Donor

10

3

Direct costs

Yes

NA

One-way

Vijayaraghavan et al. [77]

2010

Children and women of childbearing age in populations not reached by routine health services in a conflict setting

Donor

2

NR

Direct medical costs

No

NA

One-way

Wilcox et al. [78]

2013

Whole population

Healthcare system

10

3

Direct costs

Yes

NA

Multi-way

Yarahmadi et al. [79]

2010

Newborn babies

NR

70

3

Direct medical costs

NA

NA

NR

Yosefy et al. [80]

2018

Adults aged 25–64 years

NR

20

3

Direct costs

No

No

One-way

Yosefy et al. [81]

2017

All hypertensive patients

NR

10

4

Direct costs

No

No

One-way

  1. OPD out-patient department, HCV hepatitis C virus, PSA probabilistic sensitivity analysis, MoH Ministry of Health, NA not applicable, NR not reported, TB tuberculosis
  2. *In years unless otherwise stated